WIA
MIRM icon

Wetzel Investment Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Wetzel Investment Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386K Hold
3,300
– – 0.13% 85
2026
Q1 		$305K Buy
3,300
+700
+27% +$65.8K 0.12% 99
2025
Q4 		$205K Buy
+2,600
New +$187K 0.08% 131
2024
Q3 		– Sell
-2,400
Closed -$60.3K – 590
2024
Q2 		$60.3K Hold
2,400
– – 0.03% 222
2024
Q1 		$56.6K Buy
2,400
+1,000
+71% +$27.5K 0.03% 235
2023
Q4 		$41K Buy
+1,400
New +$42.4K 0.03% 268

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wetzel Investment Advisors's MIRM Position: Q2 2026 in Review

Wetzel Investment Advisors held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 3,300 shares worth $386K. The position accounts for 0.13% of the portfolio, ranked #85.

Wetzel Investment Advisors first reported a position in MIRM in Q4 2023 and has held it in 6 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Wetzel Investment Advisors held 3,300 shares of Mirum Pharmaceuticals worth $386K as of Q2 2026.
  • Wetzel Investment Advisors left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up 0.13% of Wetzel Investment Advisors's portfolio in Q2 2026, its #85 holding.
  • Wetzel Investment Advisors first reported a position in Mirum Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Wetzel Investment Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.